Role of cyclic AMP and related enzymes in rat lung growth and development.
Cyclic AMP levels in rat lungs showed phasic elevations which peaked during fetal, neonatal and late postnatal periods of development. Lung phospholipids showed major alterations in their levels during fetal and early neonatal life. Alterations in glycogen levels were accompanied by parallel changes in phosphorylase a/total phosphorylase activity which may be related to changes in cyclic AMP during development. Cyclic AMP levels were dependent on the relative activities of adenylate cyclase and cyclic AMP phosphodiesterase which also changed with age. Activation of adenylate cyclase by norepinephrine and NaF, and of cyclic AMP phosphodiesterase by calcium, was maximum neonatally and declined variably thereafter. These data suggest a relationship between cyclic AMP, glycogen and phospholipids during rat lung development.
D015105:3',5'-Cyclic-AMP Phosphodiesterases / Q000378:metabolism; D000262:Adenylyl Cyclases / Q000378:metabolism; D000818:Animals; D000831:Animals, Newborn; D000242:Cyclic AMP / Q000378:metabolism*; D006003:Glycogen / Q000378:metabolism; D008168:Lung / Q000187:drug effects / Q000196:embryology / Q000254:growth & development* / Q000378:metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism; D051381:Rats; D012969:Sodium Fluoride / Q000494:pharmacology
D010743:Phospholipids; D012969:Sodium Fluoride; D006003:Glycogen; D000242:Cyclic AMP; D015105:3',5'-Cyclic-AMP Phosphodiesterases; D000262:Adenylyl Cyclases; D009638:Norepinephrine